Anjlee Mahajan, M.D. for UC Davis Health

Anjlee Mahajan, M.D.

Assistant Professor, Division of Hematology and Oncology

To see if Anjlee Mahajan is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).





Internal Medicine

Locations and Contact

2279 45th Street
Sacramento, CA 95817

Get Directions

UC Davis Medical Group - Midtown

3160 Folsom Blvd
Sacramento, CA 95816

Get Directions

Additional Numbers

Clinic Phone


Physician Referrals

800-4-UCDAVIS (800-482-3284)

Philosophy of Care

I believe it is important to create a trustful and caring relationship with all of my patients. I aim to treat all patients as I would want my own family and friends treated. My goal is to provide you with my own expertise and education to allow you to better make healthcare decisions. I value your trust in me and look forward to partnering to improve your health.

Clinical Interests

Dr. Mahajan is a board certified hematologist and oncologist. She has a clinical and research interest in thrombosis and hemostasis (bleeding disorders). She has expertise in treatment of venous thromboembolism (including deep vein thrombosis and pulmonary embolism) as well as cancer-associated thrombosis.

Research/Academic Interests

Dr. Mahajan's research focuses on using large datasets to explore outcomes in venous thromboembolism, particularly in the area of cancer-associated thrombosis.


Hematology and Oncology

Center/Program Affiliation

UC Davis Comprehensive Cancer Center

Undergraduate School

B.S., Biology, UCLA, Los Angeles CA 2004

Medical School

M.D., Albert Einstein College of Medicine, Bronx NY 2009


Internal Medicine, UC Davis Medical Center, Sacramento CA 2009-2010


Internal Medicine, UC Davis Medical Center, Sacramento CA 2010-2012


Hematology and Oncology, UC San Francisco Medical Center, San Francisco CA 2013-2016

Sacramento Magazine Top Doctor Hematology/Oncology, UC Davis Department of Internal Medicine, 2019, 2020

Honorary participant, American Society of Hematology Medical Educator Institute, 2019

American Society of Hematology (ASH) Ambassador Program, 2018, 2019, 2020, 2021

To view a detailed list of Dr. Mahajan's publications, please click here.

Lee A, Oley F Jr, Lo M, Fong R, McGann M, Saunders I, Block S, Mahajan A, Pon TK. Direct oral anticoagulants or low-molecular-weight heparins for venous thromboembolism in patients with brain tumors. Thromb Res. 2021 Dec;208:148-155. doi:10.1016/j.thromres.2021.10.023. Epub 2021 Oct 29. PMID:34798446.

Mahajan A, Brunson A, Adesina O, Keegan THM, Wun T. The incidence of cancer-associated thrombosis is increasing over time. Blood Adv. 2022 Jan 11;6(1):307-320. doi:10.1182/bloodadvances.2021005590. PMID:34649273.

Mahajan A, White RH. In cancer-related VTE, DOACs reduce recurrent VTE compared with LMWH; groups do not differ for major bleeding. Ann Intern Med. 2020 Dec 15;173(12):JC62. doi:10.7326/ACPJ202012150-062. PMID:33316186.

Poh C, Brunson A, Keegan T, Wun T, Mahajan A. Incidence of Upper Extremity Deep Vein Thrombosis in Acute Leukemia and Effect on Mortality. TH Open. 2020 Oct 28;4(4):e309-e317. doi:10.1055/s-0040-1718883. PMID:33134806.

Hariharan N, Brunson A, Mahajan A, Keegan THM, Wun T. Bleeding in patients with sickle cell disease: a population-based study. Blood Adv. 2020 Mar 10;4(5):793-802. doi:10.1182/bloodadvances.2019000940. PMID:32108229.

Mahajan A, Brunson A, Keegan THM, Rosenberg A, Wun T. High incidence of venous thromboembolism and major bleeding in patients with primary CNS lymphoma. Leuk Lymphoma. 2020 Nov;61(11):2605-2613. doi:10.1080/10428194.2020.1780584. Epub 2020 Jun 23. PMID:32573292.